A much-awaited advisory group tasked with resolving clinical trial-related issues in the EU that sponsors, regulators and other stakeholders might face is up and running, following the appointment of the group’s second co-chair.
Denis Lacombe, chief executive officer of the European Organisation for Research and Treatment of Cancer (EORTC), was appointed as the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?